Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 3/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906167 | 0.94 | KDM1A (0.49) | PGRKDM1AHDAC9SIGMAR1TSHR | |
| SCHEMBL19130584 | 0.90 | HDAC9 (0.50) | PGRKDM1AHDAC9CYP3A4SIGMAR1 | |
| SCHEMBL5796055 | 0.90 | HDAC9 (0.50) | PGRKDM1AHDAC9CYP3A4SIGMAR1 | |
| SCHEMBL4133169 | 0.86 | CYP3A4 (0.58) | PGRKDM1ACYP3A4SIGMAR1AKR1B1 | |
| SCHEMBL7072344 | 0.82 | SLC18A3 (0.43) | PGRKDM1AHDAC9CYP3A4SIGMAR1 | |
| SCHEMBL7321561 | 0.82 | SIGMAR1 (0.51) | KDM1ACYP3A4SIGMAR1AKR1B1CYP11B1 | |
| SCHEMBL13599735 | 0.82 | PGR (0.49) | PGRKDM1ACYP3A4AKR1B1CYP17A1 | |
| SCHEMBL10590671 | 0.81 | PGR (0.51) | PGRCYP3A4SIGMAR1DRD2CYP17A1 | |
| SCHEMBL7885283 | 0.78 | BRD4 (0.40) | KDM1AHDAC9CYP3A4TP53TSHR | |
| SCHEMBL4195493 | 0.78 | KDM1A (0.50) | KDM1AHDAC9CYP3A4SIGMAR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894146-B | Synthesis method of 3-bromo-1-phenyl naphthalene | 上海固创化工新材料有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-115894146-A | Synthetic method of 3-bromo-1-phenylnaphthalene | 上海固创化工新材料有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-115894146-B | Synthesis method of 3-bromo-1-phenyl naphthalene | 上海固创化工新材料有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-115894146-B | Synthesis method of 3-bromo-1-phenyl naphthalene | 上海固创化工新材料有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2025038899-A2 | METHODS FOR CARBON DIOXIDE SEPARATION AND MATERIALS AND SYSTEMS FOR SAME | CORNELL UNIVERSITY (US) | 2025-02-20 | — | — | WO | disclosed |
| CN-115093308-B | Synthesis method of 1-bromo-4-phenyl naphthalene | 上海固创化工新材料有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-115894146-A | Synthetic method of 3-bromo-1-phenylnaphthalene | 上海固创化工新材料有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115894146-A | Synthetic method of 3-bromo-1-phenylnaphthalene | 上海固创化工新材料有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115093308-A | Synthesis method of 1-bromo-4-phenylnaphthalene | 上海固创化工新材料有限公司 | 2022-09-23 | — | — | CN | disclosed |
| US-20140088303-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | SEKISUI MEDICAL CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
| US-20140088303-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | SEKISUI MEDICAL CO., LTD. (JP) | 2014-03-27 | — | — | US | disclosed |
| US-8198445-B2 | Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2012-06-12 | — | — | US | disclosed |
| US-8198445-B2 | Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2012-06-12 | — | — | US | disclosed |
| US-20100113786-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100113786-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2128167-A1 | PHOSPHOROAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST, AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | National University Corporation Nagoya University (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-6974855-B1 | Polyimides by photochemical cyclopolymerization | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 2005-12-13 | — | — | US | disclosed |
| EP-1501830-A1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |
| US-3947520-A | Compounds and process for preparing the same | THE UPJOHN COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113786-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1C, ADH1A, DERA | PGR 2882/4885KDM1A 3189/4885HDAC9 1090/4885 |
| US-20140088303-A1 | PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1C, ADH1A, DERA | PGR 2882/4885KDM1A 3189/4885HDAC9 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.